Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-09

Clinical Trial Update: Neurofibromatosis Type 1 Brain Tumor Genetic Risk

View source ↗

Summary

Completed clinical trial investigating genetic risk factors for brain tumors in children with Neurofibromatosis Type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Neurofibromatosis Type 1, Pediatric Brain Tumor | Status: COMPLETED